These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 24449506)
21. Prognostic value of Muc5AC in gastric cancer: A meta-analysis. Zhang CT; He KC; Pan F; Li Y; Wu J World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis. Gu J; Zheng L; Wang Y; Zhu M; Wang Q; Li X Tumour Biol; 2014 Jun; 35(6):5315-21. PubMed ID: 24557541 [TBL] [Abstract][Full Text] [Related]
23. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189 [TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer]. Song S; Liu H; Xue Y Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917 [TBL] [Abstract][Full Text] [Related]
25. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China. Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance and prognostic role of microvessel density in gastric cancer: A meta-analysis. Hong WG; Ko YS; Pyo JS Pathol Res Pract; 2017 Dec; 213(12):1459-1463. PubMed ID: 29129495 [TBL] [Abstract][Full Text] [Related]
27. Investigation of ErbB-2 overexpression on patients with gastric cancer in Eastern Anatolia of Turkey. Emre H; Tekin SB; Doğan H; Çayır K; Bilici M; Sipal S; Pirim I Turk J Gastroenterol; 2013; 24(3):211-7. PubMed ID: 24226713 [TBL] [Abstract][Full Text] [Related]
28. β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis. Chen Z; He X; Jia M; Liu Y; Qu D; Wu D; Wu P; Ni C; Zhang Z; Ye J; Xu J; Huang J PLoS One; 2013; 8(5):e63854. PubMed ID: 23717499 [TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis. Cheng F; Zeng C; Zeng L; Chen Y Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathological Significance of Neuropilin 1 Expression in Gastric Cancer: A Meta-Analysis. Cao H; Li Y; Huang L; Bai B; Xu Z Dis Markers; 2020; 2020():4763492. PubMed ID: 33014187 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis. Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091 [TBL] [Abstract][Full Text] [Related]
32. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer. Cho JH; Lim JY; Cho JY World J Gastroenterol; 2017 Nov; 23(41):7407-7414. PubMed ID: 29151694 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification. Pyo JH; Ahn S; Lee H; Min BH; Lee JH; Shim SG; Choi MG; Lee JH; Sohn TS; Bae JM; Kim KM; Yeon S; Jung SH; Kim JJ; Kim S Ann Surg Oncol; 2016 Dec; 23(Suppl 5):784-791. PubMed ID: 27613552 [TBL] [Abstract][Full Text] [Related]
34. The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis. Han M; Lv S; Zhang Y; Yi R; Huang B; Fu H; Bian R; Li X Tumour Biol; 2014 May; 35(5):4589-97. PubMed ID: 24464926 [TBL] [Abstract][Full Text] [Related]
35. An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis. Wang Y; He L; Cheng Y Clin Transl Oncol; 2018 Feb; 20(2):212-220. PubMed ID: 28681313 [TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752 [TBL] [Abstract][Full Text] [Related]
37. The association of HOTAIR expression with clinicopathological features and prognosis in gastric cancer patients. Liu FT; Qiu C; Luo HL; Zhang Y; Xia GF; Hao TF; Zhu PQ Panminerva Med; 2016 Jun; 58(2):167-74. PubMed ID: 26964077 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis. Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167 [TBL] [Abstract][Full Text] [Related]
39. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis. Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178 [TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis. Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]